Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9HBG6: Variant p.Gly572Val

Intraflagellar transport protein 122 homolog
Gene: IFT122
Feedback?
Variant information Variant position: help 572 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Valine (V) at position 572 (G572V, p.Gly572Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In CED1; decreased ciliogenesis; perturbed ciliary protein trafficking; strongly decreases interaction with ITF43:WDR35; fail to assemble IFT-A complex at the cilia base. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 572 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1241 The length of the canonical sequence.
Location on the sequence: help EPNANSVAWNTQCEDMLCFS G GGYLNIKASTFPVHRQKLQG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         EPNANSVAWNTQCEDMLCFSGGGYLNIKASTFPVHRQKLQG

Mouse                         EPNANSVAWNTQCEDMLCFSGGGYLNIKASTFPVHQQKLQG

Xenopus tropicalis            EPNANSVAWNTQCEDMLCFSGGGYLNIKASNFPVHQQKLQG

Zebrafish                     EPNANSVAWNTQCEDMLCFSGGGFLNIKACSFPVHQQKLQG

Caenorhabditis elegans        EPGCYSVVFNTVNENLFAFTTNNMLHVRTLAAPGHTTRGVG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1241 Intraflagellar transport protein 122 homolog
Beta strand 567 – 572



Literature citations
Novel IFT122 mutation associated with impaired ciliogenesis and cranioectodermal dysplasia.
Alazami A.M.; Seidahmed M.Z.; Alzahrani F.; Mohammed A.O.; Alkuraya F.S.;
Mol. Genet. Genomic Med. 2:103-106(2014)
Cited for: VARIANT CED1 VAL-572; CHARACTERIZATION OF VARIANT CED1 VAL-572; Ciliopathy-associated mutations of IFT122 impair ciliary protein trafficking but not ciliogenesis.
Takahara M.; Katoh Y.; Nakamura K.; Hirano T.; Sugawa M.; Tsurumi Y.; Nakayama K.;
Hum. Mol. Genet. 27:516-528(2018)
Cited for: FUNCTION; IDENTIFICATION IN THE IFT-A COMPLEX; DOMAIN; CHARACTERIZATION OF VARIANTS CED1 CYS-7; PHE-322; ARG-495; GLY-502 AND VAL-572; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.